Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 551

Results For "IND"

6527 News Found

Polycarbin breaks the single-use scientific plastic mold
Sustainability | January 26, 2022

Polycarbin breaks the single-use scientific plastic mold

Closing the Loop on single-use plastics


Intellect closes US $10 m Series A to scale mental healthcare across Asia
Startup | January 26, 2022

Intellect closes US $10 m Series A to scale mental healthcare across Asia

The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners


Philips introduces at-home, 12-lead ECG integrated solution for trials
Medical Device | January 26, 2022

Philips introduces at-home, 12-lead ECG integrated solution for trials

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials


JBCPL to acquire brands from Sanzyme for Rs 628 cr
News | January 26, 2022

JBCPL to acquire brands from Sanzyme for Rs 628 cr

Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise


JSW opens 300-bed covid centre in Karnataka
Public Health | January 25, 2022

JSW opens 300-bed covid centre in Karnataka

The covid health center will be managed and administered by the district administration of Ballari


USFDA rejects Merck’s gefapixant; gain approval in Japan
News | January 25, 2022

USFDA rejects Merck’s gefapixant; gain approval in Japan

Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant


Medtronic gets USFDA approval of spinal cord stimulation therapy
Medical Device | January 25, 2022

Medtronic gets USFDA approval of spinal cord stimulation therapy

Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone


SQI Diagnostics inks pact with UK-Based Owlstone Medical
Biotech | January 25, 2022

SQI Diagnostics inks pact with UK-Based Owlstone Medical

Companies plan to commercialize breath-based detection of lung infection and transplant rejection


Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation
News | January 25, 2022

Control Print’s 3-ply surgical masks receive USFDA 510(K) authorisation

The company has been manufacturing masks since the Covid-19 outbreak in 2020


Sanofi signs as first partner of Protas
Biotech | January 25, 2022

Sanofi signs as first partner of Protas

The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases